Wordt geladen...
‘Les liaisons dangereuses’: Hepatitis C, Rituximab and B-cell non-Hodgkin’s lymphomas
Rituximab has provided a revolutionary contribution to the treatment of B-cell non-Hodgkin’s lymphomas (NHL). A high prevalence of hepatitis C virus (HCV) infection has been described in B-cell NHL patients. Cases of liver dysfunction in HCV-positive patients have been reported with Rituximab-contai...
Bewaard in:
Hoofdauteurs: | , , , , , , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Baishideng Publishing Group Co., Limited
2012
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3348959/ https://ncbi.nlm.nih.gov/pubmed/22577616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4292/wjgpt.v3.i2.21 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|